Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

Brain

Volumn 120, Issue 11, 1997, Pages 2059-2069

  Barkhof, Frederik ^a   Filippi, Massimo ^c   Miller, David H ^d   Scheltens, Philip ^a   Campi, Adriana ^c   Polman, Chris H ^a   Comi, Giancarlo ^c   Adèr, Herman J ^a,b   Losseff, Nick ^d   Valk, Jacob ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Brain; Diagnosis; Gadolinium; MRI; Multiple sclerosis

Indexed keywords

GADOLINIUM;

ARTICLE; BRAIN CORTEX; DIAGNOSTIC ACCURACY; HUMAN; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS;

EID: 0030832846     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.11.2059     Document Type: Article

References (42)

1. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991: 336-58.
2. Barkhof F, Scheltens P, Frequin STFM, Nauta JJ, Tas MW, Valk J, et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 1992; 159: 1041-7.
3. Caldemeyer KS, Smith RR, Harris TM, Edwards MK. MRI in acute disseminated encephalomyelitis. Neuroradiology 1994; 36: 216-20.
4. Campi A, Filippi M, Comi G, Martinelli V, Baratti C, Rovaris M, et al. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. Am J Neuroradiol 1995; 16: 115-23.
5. Dawson JW. The histology of disseminated sclerosis. Trans Roy Soc Edinb 1916; 50: 517-740.
6. Fazekas F, Offenbacher H, Fuchs S, Schmidt R, Niederkorn K, Horne S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988; 38: 1822-5.
7. Filippi M, Horsfield MA, Morrissey SP, MacManus DG, Rudge P, McDonald WI, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994; 44: 635-41.
8. Filippi M, Mammi S, Yousry T, Becker C, Baratti C, Voltz R, et al. Comparison of fast-FLAIR vs conventional SE sequences for measurement of brain MRI lesion load in patients with multiple sclerosis [abstract]. J Neuroimmunol 1995; Suppl 1: 62.
9. Fog T. The topography of plaques in multiple sclerosis: with special reference to cerebral plaques. Acta Neurol Scand 1965; 14 Suppl 15: 157-9.
10. Gean-Marton AD, Vezina LG, Marton KI, Stimac GK, Peyster RG, Taveras JM, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis [see comments]. Radiology 1991; 180: 215-21. Comment in: Radiology 1991; 180: 15-7.
11. Gean-Marton AD, Vezina LG, Marton KI, Stimac GK, Peyster RG, Taveras JM, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis [see comments]. Radiology 1991; 180: 215-21. Comment in: Radiology 1991; 180: 15-7.
12. Gebarski SS, Gabrielsen TO, Gilman S, Knake JE, Latack JT, Aisen AM. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging. Ann Neurol 1985; 17: 469-74.
13. Grossman RI, Gonzalez-Scarano F, Atlas SW, Galetta S, Silberberg DH. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986; 161: 721-5.
14. Hashemi RH, Bradley WG Jr, Chen DY, Jordan JE, Queralt JA, Cheng AE, et al. Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence. Radiology 1995; 196: 505-10.
15. Hawkins CP, Munro PMG, MacKenzie F, Kesselring J, Tofts PS, du Boulay EP, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990; 113: 365-78.
16. Herndon RM, Brooks B. Misdiagnosis of multiple sclerosis. Semin Neurol 1985; 5: 94-8.
17. Heun R, Kappos L, Bittkau S, Städt D, Rohrbach E, Schuknecht B. Magnetic resonance imaging and early diagnosis of multiple sclerosis [letter]. Lancet 1988; 2: 1202-3.
18. Horowitz AL, Kaplan RD, Grewe G, White RT, Salberg LM. The ovoid lesion: a new MR observation in patients with multiple sclerosis. AJNR Am J Neuroradiol 1989; 10: 303-5.
19. Kappos L, Gold R, Städt D, Heun R, Keil W, Radü EW. MS: definite diagnosis at first presentation? The role of Gd-enhanced MRI [abstract]. Neurology 1991; 41 Suppl 1: 168.
20. Katz D, Taubenberger J, Raine C, McFarlin D, McFarland H. Gadolinium-enhancing lesions on magnetic resonance imaging: neuropathological findings [abstract]. Ann Neurol 1990; 28: 243.
21. Kazui S, Naritomi H, Imakita S, Yamada N, Ogawa M, Sawada T. Sequential gadolinium-DTPA enhanced MRI studies in neuro-Behçet's disease. Neuroradiology 1991; 33: 136-9.
22. Lee KH, Hashimoto S, Hooge JP, Kastrukoff LF, Oger JJ, Li DK, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1991; 41: 657-60.
23. Lee DH, Vellet AD, Eliasziw M, Vidito L, Ebers GC, Rice GP, et al. MR imaging field strength: prospective evaluation of the diagnostic accuracy of MR for diagnosis of multiple sclerosis at 0.5 and 1.5 T. Radiology 1995; 194: 257-62.
24. Lumsden CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 9. Amsterdam: North-Holland, 1970: 217-309.
25. Miller DH, Ormerod IEC, Gibson A, du Boulay EPGH, Rudge P, McDonald WI. MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 1987; 29: 226-31.
26. Morissey SP, Miller Dh, Kendall BE, Kingsley DP, Kelly MA, Francis DA, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 1993; 116: 135-46.
27. Morrissey SP, Stodal H, Zettl U, Simonis C, Jung S, Kiefer R, et al. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain 1996; 119: 239-48.
28. Namer IJ. Yu O, Mauss Y, Dumitresco BE, Chambron J. An evaluation of the significance of areas of intense signal in the MR brain images of patients with multiple sclerosis. Magn Reson Imaging 1993; 11: 311-7.
29. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991; 180: 467-74.
30. Offenbacher H, Fazekas F, Schmidt R, Fiedl W, Flooh E, Payer F, et al. Assessment of MRI criteria for a diagnosis of MS Neurology 1993; 43: 905-9.
31. Paty DW, Oger JJF, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.Neurology 1988; 38: 180-5.
32. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
33. Runge VM, Price AC, Kirshner HS, Allen JH, Partain CL, James AE Jr. Magnetic resonance imaging of multiple sclerosis: a study of pulse-technique efficacy. AJR Am J Roentgenol 1984; 143: 1015-26.
34. Schumacher GA, Beebe G, Kibler RE, Kurland LT, Kurtzke JF, Mcdowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552-68.
35. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJNR Am J Neuroradiol 1990; 11: 915-23.
36. Simon JH, Holtås SL, Schiffer RB, Rudick RA, Herndon RN, Kido DK, et al. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR. Radiology 1986; 160: 363-7.
37. Tas MW, Barkhof F, van Walderveen MAA, Polman CH, Hommes OR, Valk J. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR Am J Neuroradiol 1995; 16: 259-64.
38. Thorpe JW, Kidd D, Moseley IF, Thompson AJ, MacManus DG, Compston DA, et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 1996; 119: 709-14.
39. 1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE). [Review]. Neuroradiology 1989; 31: 203-12.
40. van der Knaap MS, Valk J. Magnetic resonance of myelin, myelination, and myelin disorders. 2nd ed. Berlin: Springer Verlag, 1995.
41. 1-weighted) spin-echo images. Neurology 1995; 45: 1684-90.
42. Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114: 2437-50.